[{"Assets_0_Q2_USD":210881000.0,"CommonStockSharesOutstanding_0_Q2_shares":26801717.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-82419000.0,"NetIncomeLoss_1_Q2_USD":-45730000.0,"NetIncomeLoss_2_Q2_USD":-91860000.0,"StockholdersEquity_0_Q2_USD":175917000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]